We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Certolizumab

Australian Public Assessment Report

AusPAR

AusPAR: Certolizumab [PDF, 2.03 MB]

AusPAR: Certolizumab [Word, 986.95 KB]

Attachment: Product Information: Cimzia [PDF, 334.33 KB]

Attachment: Product Information: Cimzia [Word, 182.73 KB]

Attachment: Extract from Clinical Evaluation Report: Certolizumab [PDF, 1.31 MB]

Attachment: Extract from Clinical Evaluation Report: Certolizumab [Word, 456.51 KB]

Device/Product Name

Cimzia

Active ingredients

Certolizumab

AusPAR Date

15 August 2014

Published

30 September 2014

Submission Number

PM-2013-00286-2-3

Submission Type

Extension of indications

Decision

Approved